CSS
CABA icon

Cubist Systematic Strategies’s Cabaletta Bio CABA Stock Holding History

Cubist Systematic Strategies’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$88.3K Sell
37,744
-197,526
-84% -$339K ﹤0.01% 2789
2025
Q2 		$358K Buy
+235,270
New +$367K ﹤0.01% 2389
2025
Q1 		– Sell
-217,802
Closed -$494K – 2905
2024
Q4 		$494K Sell
217,802
-355,378
-62% -$1.25M ﹤0.01% 2181
2024
Q3 		$2.71M Buy
+573,180
New +$3.32M 0.02% 1241
2024
Q2 		– Sell
-137,538
Closed -$2.35M – 3052
2024
Q1 		$2.35M Buy
137,538
+108,297
+370% +$2.32M 0.01% 1519
2023
Q4 		$664K Buy
+29,241
New +$492K ﹤0.01% 2358
2023
Q2 		– Sell
-36,457
Closed -$301K – 3559
2023
Q1 		$301K Buy
+36,457
New +$341K ﹤0.01% 2992
2022
Q1 		– Sell
-22,880
Closed -$87K – 3570
2021
Q4 		$87K Buy
22,880
+12,106
+112% +$129K ﹤0.01% 3229
2021
Q3 		$131K Sell
10,774
-3,154
-23% -$29.1K ﹤0.01% 2691
2021
Q2 		$120K Buy
+13,928
New +$137K ﹤0.01% 2694
2020
Q1 		– Sell
-5,505
Closed -$77K – 2183
2019
Q4 		$77K Buy
+5,505
New +$65.2K ﹤0.01% 2234

Other funds holding CABA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return

Cubist Systematic Strategies's CABA Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Cabaletta Bio (CABA) stake by 84% in Q3 2025, selling an estimated $339K and leaving 37,744 shares worth $88.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2789.

Cubist Systematic Strategies first reported a position in CABA in Q4 2019 and has held it in 11 quarters since. The position peaked at $2.71M in Q3 2024. 75 funds tracked by Wall St. Rank hold CABA as of Q3 2025.

  • Cubist Systematic Strategies held 37,744 shares of Cabaletta Bio worth $88.3K as of Q3 2025.
  • Cubist Systematic Strategies sold 197,526 Cabaletta Bio shares in Q3 2025, an estimated $339K.
  • Cabaletta Bio made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2789 holding.
  • Cubist Systematic Strategies first reported a position in Cabaletta Bio in Q4 2019 and has held it in 11 quarters since.
  • Cubist Systematic Strategies's Cabaletta Bio position peaked at $2.71M in Q3 2024.
  • 75 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.